Clostridioides difficile-related reactive arthritis: A scoping review of the literature (2025)
https://pubmed.ncbi.nlm.nih.gov/40484294/

Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic, and imaging associations (2025)
https://pubmed.ncbi.nlm.nih.gov/40059325/

Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry (2025)
https://pubmed.ncbi.nlm.nih.gov/39893938/

Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study (2025)
https://pubmed.ncbi.nlm.nih.gov/38092032/

Clinical Outcomes and Patients’ Perspectives of Multidisciplinary Psoriasis Management: A Five-Year Retrospective Study (2024)
https://pubmed.ncbi.nlm.nih.gov/39463870/

Monotherapy or combination therapy in PsA: current aspects (2024)
https://pubmed.ncbi.nlm.nih.gov/39314822/

Significant overlap of inflammatory and degenerative features on imaging among patients with degenerative disc disease, diffuse idiopathic skeletal hyperostosis and axial spondyloarthritis: a real-life cohort study (2024)
https://pubmed.ncbi.nlm.nih.gov/39097721/

Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry (2024)
https://pubmed.ncbi.nlm.nih.gov/38759119/

Focus on Filgotinib in Rheumatoid Arthritis: A Trial-Based Review (2024)
https://pubmed.ncbi.nlm.nih.gov/38756936/

Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic Arthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/38282940/

Quality-of-Life Endpoints in Women of Childbearing Age with Hidradenitis Suppurativa: A Tertiary-Care-Centre-Based Study (2023)
https://pubmed.ncbi.nlm.nih.gov/38282935/

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37731083/

Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study (2023)
https://pubmed.ncbi.nlm.nih.gov/37610650/

Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment (2023)
https://pubmed.ncbi.nlm.nih.gov/37584210/

Cost of Illness, Quality of Life, and Work Productivity in Axial Spondyloarthritis Patients Receiving Biological Treatments in Greece (2023)
https://pubmed.ncbi.nlm.nih.gov/37223606/

Positron Emission-Computed Tomography, Cryobiopsy versus Bronchoalveolar Lavage and Computed Tomography Findings for Interstitial Lung Disease: A Long-Term Follow-Up (2023)
https://pubmed.ncbi.nlm.nih.gov/37109746/

Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease (2023)
https://pubmed.ncbi.nlm.nih.gov/36840819/

Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study (2022)
https://pubmed.ncbi.nlm.nih.gov/36397162/

Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review (2022)
https://pubmed.ncbi.nlm.nih.gov/35849191/

Real-life intraclass switch among IL-17 inhibitors in psoriasis: results from a single-centre, 24-week, retrospective study (2022)
https://pubmed.ncbi.nlm.nih.gov/35770467/

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study (2022)
https://pubmed.ncbi.nlm.nih.gov/35655317/

Apremilast Survival and Reasons for Discontinuation in Psoriasis: Five-Year Experience From a Greek Tertiary Care Centre (2022)
https://pubmed.ncbi.nlm.nih.gov/35646455/

Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/34758975/

When the low may still be high: the heavy burden of residual psoriasis in difficult-to-treat areas despite a low DLQI score among patients under biologics or apremilast: a 5-year, prospective, case-control study (2022)
https://pubmed.ncbi.nlm.nih.gov/34553801/

Bilateral Recurrent Uveitis in a Young Patient with Family History of Spondyloarthritis: Spondyloarthritis or Not? (2021)
https://pubmed.ncbi.nlm.nih.gov/34964032/

Modification of Apremilast from Pills to Aerosol a Future Concept (2021)
https://pubmed.ncbi.nlm.nih.gov/34770103/

Relapsing polychondritis with sterile purulent perichondrial effusions responding to Infliximab in a patient with erythrodermic and pustular psoriasis (2021)
https://pubmed.ncbi.nlm.nih.gov/34243186/

Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review (2021)
https://pubmed.ncbi.nlm.nih.gov/34009397/

Outcome of refractory to conventional and/or biologic treatment adult Still’s disease following canakinumab treatment: Countrywide data in 50 patients (2021)
https://pubmed.ncbi.nlm.nih.gov/33383289/

Successful treatment of Cogan’s syndrome with tocilizumab (2021)
https://pubmed.ncbi.nlm.nih.gov/33047628/

Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/33239083/

Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI) (2020)
https://pubmed.ncbi.nlm.nih.gov/32703843/

Eosinophilic Fasciitis in a Patient With Crohn’s Disease Treated With Infliximab. A Rare Coexistence or a Drug-related Manifestation? (2020)
https://pubmed.ncbi.nlm.nih.gov/32529216/

The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital (2019)
https://pubmed.ncbi.nlm.nih.gov/32185344/

Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis (2019)
https://pubmed.ncbi.nlm.nih.gov/32185343/

Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus (2018)
https://pubmed.ncbi.nlm.nih.gov/32185334/

Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up (2018)
https://pubmed.ncbi.nlm.nih.gov/30060102/

In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study (2018)
https://pubmed.ncbi.nlm.nih.gov/29533750/

Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study (2018)
https://pubmed.ncbi.nlm.nih.gov/28850029/

Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population (2017)
https://pubmed.ncbi.nlm.nih.gov/27440135/

Cognitive deficits early in the course of rheumatoid arthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27133019/

Adaptation to an autoimmune disorder: Does mental flexibility impact illness-related self-regulation? (2016)
https://pubmed.ncbi.nlm.nih.gov/26286095/

Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence (2015)
https://pubmed.ncbi.nlm.nih.gov/25908179/